中国中免：前三季度净利润30.52亿元，同比下降22.13%

Core Insights - China National Pharmaceutical Group (China National Medicine) reported a decline in both revenue and net profit for the third quarter of 2025, indicating ongoing pressure from slowing consumer demand [1] Financial Performance - The company's third-quarter revenue was 11.711 billion yuan, a year-on-year decrease of 0.38% [1] - Net profit for the third quarter was 452 million yuan, down 28.94% year-on-year [1] - For the first three quarters of 2025, total revenue reached 39.862 billion yuan, reflecting a year-on-year decline of 7.34% [1] - Net profit for the first three quarters was 3.052 billion yuan, a decrease of 22.13% compared to the same period last year [1] Market Conditions - The company's performance is under continuous pressure due to a slowdown in consumer demand, impacting overall operational results [1]